Existing studies have reported that inhibition of CXCL8 attenuates high-glucose-induced renal tubular cell-mediated inflammation and apoptosis in diabetic kidney disease (Bai et al., 2022). This evidence concerns the gene CXCL8 and diabetic kidney disease.